IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights

The insulin-like growth factor-I (IGF-I) signaling induces epithelial to mesenchymal transition (EMT) program and contributes to metastasis and drug resistance in several subtypes of tumors. In preclinical studies, targeting of the insulin-like growth factor-I receptor (IGF-IR) showed promising anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Heming, Batth, Izhar Singh, Qu, Xiujuan, Xu, Ling, Song, Na, Wang, Ruoyu, Liu, Yunpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282886/
https://www.ncbi.nlm.nih.gov/pubmed/28137302
http://dx.doi.org/10.1186/s12943-016-0576-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282886/
https://www.ncbi.nlm.nih.gov/pubmed/28137302
http://dx.doi.org/10.1186/s12943-016-0576-5

Ejemplares similares